Company intelligence / Profile preview
N. R. Biotech
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
Overview
N. R. Biotech manufactures, supplies, and exports approved and commercial-stage pharmaceuticals including injections, vaccines, and biological infusions, focused on treatment and prevention of infectious diseases and critical care. The company is small, established in 2016, with up to 10 employees and a turnover of ₹5-25 Cr (INR). Its products are available in domestic and export markets.
- Therapeutic areas
- HematologyInfectious DiseasesGastroenterologyOther
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on N. R. Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on N. R. Biotech.